Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular CarcinomaJordi Bruix, Morris Sherman, María Reig|Gastroenterology|2016Cited by 1.8k
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Xavier Forns et al.|Gut|2021Cited by 96
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Caldéraro, Haeryoung Kim, Narmin Ghaffari Laleh et al.|Nature Communications|2023Cited by 76
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future TrialsGiuseppe Cabibbo, Calogero Cammà, María Reig et al.|Liver Cancer|2021Cited by 50
Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practiceGiuseppe Cabibbo, María Reig, Ciro Celsa et al.|Journal of Hepatology|2024Cited by 50